- Home
- BLRX vs AIFU Comparison
BLRX vs AIFU Comparison
Compare BLRX & AIFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- AIFU
- Stock Information
- Founded
- BLRX 2003
- AIFU 1998
- Country
- BLRX Israel
- AIFU China
- Employees
- BLRX N/A
- AIFU N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- AIFU
- Sector
- BLRX Health Care
- AIFU
- Exchange
- BLRX Nasdaq
- AIFU NYSE
- Market Cap
- BLRX 15.3M
- AIFU 12.2M
- IPO Year
- BLRX 2011
- AIFU 2007
- Fundamental
- Price
- BLRX $4.53
- AIFU $6.20
- Analyst Decision
- BLRX Strong Buy
- AIFU
- Analyst Count
- BLRX 2
- AIFU 0
- Target Price
- BLRX $19.00
- AIFU N/A
- AVG Volume (30 Days)
- BLRX 217.2K
- AIFU 191.3K
- Earning Date
- BLRX 08-14-2025
- AIFU 07-11-2025
- Dividend Yield
- BLRX N/A
- AIFU N/A
- EPS Growth
- BLRX N/A
- AIFU 61.54
- EPS
- BLRX N/A
- AIFU 23.02
- Revenue
- BLRX $22,340,000.00
- AIFU $247,815,758.00
- Revenue This Year
- BLRX N/A
- AIFU N/A
- Revenue Next Year
- BLRX N/A
- AIFU N/A
- P/E Ratio
- BLRX N/A
- AIFU $0.26
- Revenue Growth
- BLRX 91.68
- AIFU N/A
- 52 Week Low
- BLRX $2.30
- AIFU $1.50
- 52 Week High
- BLRX $35.60
- AIFU $7.59
- Technical
- Relative Strength Index (RSI)
- BLRX 52.05
- AIFU N/A
- Support Level
- BLRX $4.20
- AIFU N/A
- Resistance Level
- BLRX $4.62
- AIFU N/A
- Average True Range (ATR)
- BLRX 0.43
- AIFU 0.00
- MACD
- BLRX -0.09
- AIFU 0.00
- Stochastic Oscillator
- BLRX 34.42
- AIFU 0.00
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About AIFU FANHUA INC SPON ADS EACH REPR 20 ORD SHS
AIFU Inc is an independent financial services provider in China. It offer end-to-end business solutions spanning compliance, technology, products, services, capital flow and professional training. It connects customers with insurance protection, retirement planning, health management, asset management, and family governance services. The company operated in two segments: the insurance agency segment, which derives maximum revenue, consists of providing agency services for distributing life insurance products and non-life insurance products on behalf of insurance companies, and the claims adjusting segment consisting of providing pre-underwriting survey services, claims adjusting services, disposal of residual value services, loading/unloading supervision services and consulting services.